Morphic Financial Statements From 2010 to 2024
Morphic Holding financial statements provide useful quarterly and yearly information to potential Morphic Holding investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Morphic Holding financial statements helps investors assess Morphic Holding's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Morphic Holding's valuation are summarized below:Morphic Holding does not presently have any fundamental ratios for analysis.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Check Morphic Holding financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Morphic Holding's main balance sheet or income statement drivers, such as , as well as many indicators such as . Morphic financial statements analysis is a perfect complement when working with Morphic Holding Valuation or Volatility modules.
Morphic |
Morphic Holding Company Return On Asset Analysis
Morphic Holding's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Morphic Holding Return On Asset | -0.19 |
Most of Morphic Holding's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Morphic Holding is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
CompetitionBased on the latest financial disclosure, Morphic Holding has a Return On Asset of -0.1909. This is 97.82% lower than that of the Biotechnology sector and 99.19% lower than that of the Health Care industry. The return on asset for all United States stocks is 36.36% higher than that of the company.
Morphic Holding Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Morphic Holding's current stock value. Our valuation model uses many indicators to compare Morphic Holding value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Morphic Holding competition to find correlations between indicators driving Morphic Holding's intrinsic value. More Info.Morphic Holding is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Morphic Holding by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About Morphic Holding Financial Statements
Morphic Holding stakeholders use historical fundamental indicators, such as Morphic Holding's revenue or net income, to determine how well the company is positioned to perform in the future. Although Morphic Holding investors may analyze each financial statement separately, they are all interrelated. For example, changes in Morphic Holding's assets and liabilities are reflected in the revenues and expenses on Morphic Holding's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Morphic Holding. Please read more on our technical analysis and fundamental analysis pages.
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Morphic Holding, Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts. Morphic Holding operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 101 people.
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Consideration for investing in Morphic Stock
If you are still planning to invest in Morphic Holding check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Morphic Holding's history and understand the potential risks before investing.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |